- Home
- IKT vs KINS Comparison
IKT vs KINS Comparison
Compare IKT & KINS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IKT
- KINS
- Stock Information
- Founded
- IKT 2008
- KINS 1886
- Country
- IKT United States
- KINS United States
- Employees
- IKT N/A
- KINS N/A
- Industry
- IKT Biotechnology: Pharmaceutical Preparations
- KINS Property-Casualty Insurers
- Sector
- IKT Health Care
- KINS Finance
- Exchange
- IKT Nasdaq
- KINS Nasdaq
- Market Cap
- IKT 168.0M
- KINS 197.1M
- IPO Year
- IKT 2020
- KINS N/A
- Fundamental
- Price
- IKT $2.00
- KINS $21.67
- Analyst Decision
- IKT Buy
- KINS Strong Buy
- Analyst Count
- IKT 2
- KINS 1
- Target Price
- IKT $8.00
- KINS $6.50
- AVG Volume (30 Days)
- IKT 113.6K
- KINS 381.5K
- Earning Date
- IKT 05-14-2025
- KINS 05-08-2025
- Dividend Yield
- IKT N/A
- KINS N/A
- EPS Growth
- IKT N/A
- KINS 5417.04
- EPS
- IKT N/A
- KINS 1.60
- Revenue
- IKT N/A
- KINS $169,875,701.00
- Revenue This Year
- IKT N/A
- KINS $40.63
- Revenue Next Year
- IKT N/A
- KINS $6.92
- P/E Ratio
- IKT N/A
- KINS $13.35
- Revenue Growth
- IKT N/A
- KINS 18.52
- 52 Week Low
- IKT $1.12
- KINS $4.01
- 52 Week High
- IKT $4.20
- KINS $20.16
- Technical
- Relative Strength Index (RSI)
- IKT 46.57
- KINS 67.78
- Support Level
- IKT $1.78
- KINS $16.60
- Resistance Level
- IKT $2.13
- KINS $18.88
- Average True Range (ATR)
- IKT 0.16
- KINS 1.38
- MACD
- IKT -0.01
- KINS 0.20
- Stochastic Oscillator
- IKT 37.61
- KINS 91.06
About IKT Inhibikase Therapeutics Inc.
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.
About KINS Kingstone Companies Inc.
Kingstone Companies Inc is a multi-line regional property and casualty insurance holding company. It offers insurance policies to small and mid-sized businesses as well as to individuals.